Cargando…

Sensory neural hearing loss in Behcet's disease successfully controlled with infliximab, case report and review of literature

Behcet's disease is a systemic autoimmune disorder occasionally associated with otological manifestations, including sensorineural hearing loss. We are reporting a case of Behcet's disease, which was complicated by sensorineural hearing loss and managed successfully with anti‐TNF agent Inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faisal, Mohanad, Barjas, Haidar, Alwassiti, Wisam, Omer, Walid, Abdulla, Nabeel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557016/ https://www.ncbi.nlm.nih.gov/pubmed/36254147 http://dx.doi.org/10.1002/ccr3.6457

Ejemplares similares

Aortic Arch Aneurysm in Behçet Disease Successfully Treated with Infliximab
por: Nishiyama, Taihei, et al.
Publicado: (2020)

Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
por: Nakamura, Akihiro, et al.
Publicado: (2016)

Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab
por: Fujiwara, Shun, et al.
Publicado: (2022)

Metabolic syndrome and idiopathic sudden sensori-neural hearing loss
por: Rinaldi, Massimo, et al.
Publicado: (2020)

Age-Related Hearing Loss: Sensory and Neural Etiology and Their Interdependence
por: Elliott, Karen L., et al.
Publicado: (2022)

Infliximab for severe ocular inflammation in patients with Behcet's disease
por: Sfikakis, P, et al.
Publicado: (2003)

363. Autoimmune Sensory Neural Hearing Loss Apparently Triggered by Neurocysticercosis
por: Davies, Evan, et al.
Publicado: (2022)

Infliximab is a plausible alternative for neurologic complications of Behçet disease
por: Zeydan, Burcu, et al.
Publicado: (2016)

Frequency of Sensory Neural Hearing Loss in Major Beta-Thalassemias in Southern Iran
por: Faramarzi, Abolhassan, et al.
Publicado: (2010)

The Effect of Infliximab Therapy on Maculopathy in Behcet's Panuveitis: A Case Report
por: Sahin, Ozlem G.
Publicado: (2011)

Cystoid Macular Edema: Possible Complication of Infliximab Therapy in Behçet's Disease
por: Ikewaki, Junko, et al.
Publicado: (2010)

Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study
por: Esatoglu, Sinem Nihal, et al.
Publicado: (2020)

Prevalence of Epileptiform Discharges in Children with Sensori-Neural Hearing Loss and Behavioral Problems Compared to Their Normal Hearing Peers
por: AMIRSALARI, Susan, et al.
Publicado: (2014)

Time from sudden sensory neural hearing loss to treatment as a prognostic factor
por: Chen, Itay, et al.
Publicado: (2023)

Cataract Surgery in Behçet's Disease Patients One Week after Infliximab Administration
por: Handa, Tsuneaki, et al.
Publicado: (2011)

Trabeculotomy in a Behçet's Disease Patient One Week after Infliximab Administration
por: Koike, Aya, et al.
Publicado: (2012)

Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
por: Takeuchi, Masaru, et al.
Publicado: (2015)

Hearing Loss: Reestablish the Neural Plasticity in Regenerated Spiral Ganglion Neurons and Sensory Hair Cells
por: Chai, Renjie, et al.
Publicado: (2017)

Sensory-Neural Hearing Loss as an Early Rebound Relapse after Fingolimod Cessation in Multiple Sclerosis
por: Naser Moghadasi, Abdoreza, et al.
Publicado: (2020)

Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report
por: Li, Yue, et al.
Publicado: (2013)

Efficacy of infliximab in neuro-Behçet’s disease presenting with isolated longitudinally extensive transverse myelitis
por: Kuroda, Ryo, et al.
Publicado: (2013)

Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test
por: Kotecha, Jalpa, et al.
Publicado: (2016)

Herpetic Keratouveitis and Trabeculectomy Failure during Infliximab Therapy in a Patient with Behçet’s Disease
por: Gür Güngör, Sirel, et al.
Publicado: (2016)

A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020)

Infliximab-Induced Granulomatous Vasculitis With Amyloid Deposition in the Tongue of a Patient With Behçet Disease
por: Iwasaki, Sari, et al.
Publicado: (2021)

Pembrolizumab-Induced Rhabdomyolysis in a Clear Cell Renal Cell Carcinoma Patient: A Case Report
por: Altermanini, Mohammad, et al.
Publicado: (2023)

Hearing Loss: Reestablish the Neural Plasticity in Regenerated Spiral Ganglion Neurons and Sensory Hair Cells 2018
por: Chai, Renjie, et al.
Publicado: (2018)

Extended High Frequency Audiometry for Revealing Sudden Sensory Neural Hearing Loss in Acute Tinnitus Patients
por: Abu-Eta, Rani, et al.
Publicado: (2021)

A Prospective Study on Post Covid Sudden Onset Sensory Neural Hearing Loss and Its Recovery
por: Kandakure, Vinod T., et al.
Publicado: (2023)

Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015)

Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
por: Katsuyama, Atsuko, et al.
Publicado: (2019)

Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease
por: Alfawaz, Abullah, et al.
Publicado: (2014)

Reperfusion of retinal ischemia in retinal occlusive vasculitis with nicotinic acid and infliximab in Adamantiades-Behçet's disease
por: Al-Moujahed, Ahmad, et al.
Publicado: (2021)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)
por: Cheon, Jae Hee, et al.
Publicado: (2023)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
por: Subedi, Smriti, et al.
Publicado: (2019)

Correlation of SVINT and Sensory Organization Test in Children with Hearing Loss
por: Sinno, Solara, et al.
Publicado: (2022)

Comparison of sensory–Neural Hearing between Firefighters and Office Workers
por: Assadi, Seyedeh Negar, et al.
Publicado: (2013)

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
por: Lee, Jung Hoon, et al.
Publicado: (2007)

Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report
por: Marsili, Manuela, et al.
Publicado: (2016)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cs2in6mpuptrp5j4o4gsnkmo64